Catabasis Pharmaceuticals, Inc. CATB
$ 8.54
-6.97%
Catabasis Pharmaceuticals, Inc. Financial Ratios 2011-2024 | CATB
Annual Financial Ratios Catabasis Pharmaceuticals, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.2 | -2.4 | -1.2 | -1.2 | -1.8 | -1.6 | - | - | - | - |
P/S |
- | - | - | 64.2 | - | - | - | - | - | - |
EV/EBITDA |
-1.6 | -1.9 | -0.6 | -0.7 | -1.3 | 0.0 | - | - | - | - |
PEG |
0.05 | -0.04 | -0.02 | -0.03 | -0.04 | 0.03 | - | - | - | - |
P/B |
2.0 | 1.7 | 0.9 | 2.7 | 2.2 | 1.1 | - | - | - | - |
P/CF |
-2.5 | -2.3 | -1.3 | -1.2 | -1.9 | -1.8 | - | - | - | - |
ROE % |
-91.72 | -73.61 | -74.04 | -232.06 | -123.98 | -64.62 | - | - | - | - |
ROA % |
-78.60 | -62.93 | -66.05 | -152.90 | -89.68 | -50.81 | - | - | - | - |
ROCE % |
-91.16 | -73.71 | -75.35 | -228.04 | -111.52 | -56.12 | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - |
All numbers in USD currency